Leukemia Research
Volume 26, Issue 11 , Pages 1027-1033 , November 2002

Multicolor-FISH analysis of a natural killer cell line (NK-92)

  • Roderick A.F MacLeod

      Affiliations

    • DSMZ, German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany
    • Corresponding Author InformationCorresponding author. Present address: DSMZ, Department Human & Animal Cell Cultures, Mascheroder Weg 1b, 38124, Braunschweig, Germany. Tel.: +49-531-2616157; fax: +49-531-2616150.
    web address
    • ,
  • Stefan Nagel

      Affiliations

    • DSMZ, German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany
    • ,
  • Maren Kaufmann

      Affiliations

    • DSMZ, German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany
    • ,
  • Karin Greulich-Bode

      Affiliations

    • DKFZ, German Cancer Research Centre, Heidelberg, Germany
    • ,
  • Hans G Drexler

      Affiliations

    • DSMZ, German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany

Received 26 November 2001 ,Accepted 4 March 2002.

References 

  1. Kingreen D, Siegert W. Chronic lymphatic leukemias of T and NK cell type. Leukemia. 1997;11(Suppl 2):S46–S49
  2. Rakozy CK, Mohamed AN, Vo TD, Khatib G, Long PM, Eilender D, et al. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse. Am J Clin Pathol. 2001;116:168–176
  3. Sun T, Brody J, Susin M, Marino J, Teichberg S, Koduru P, et al. Aggressive NK cell lymphoma/leukemia. A recently recognized clinicopathologic entity. Am J Surg Pathol. 1993;17:1289–1299
  4. Tien HF, Su IJ, Tang JL, Liu MC, Lee FY, Chen YC, et al. Clonal chromosomal abnormalities as direct evidence for clonality in nasal T/NK cell lymphomas. Br J Haematol. 1997;97:621–625
  5. Wong KF, Chan JK, Kwong YL. Identification of del(6)(q21q25) as a recurring chromosomal abnormality in putative NK cell lymphoma/leukaemia. Br J Haematol. 1997;98:922–926
  6. Wong KF, Chan JK, Yu PH, So CC. A man with NK cell lymphoma showing 46,XX and deletion 6q. Cancer Genet Cytogenet. 1999;112:165–168
  7. Wong KF, Zhang YM, Chan JK. Cytogenetic abnormalities in NK cell lymphoma/leukemia is there a consistent pattern?. Leuk Lymphoma. 1999;34:241–250
  8. Wong N, Wong KF, Chan JK, Johnson PJ. Chromosomal translocations are common in NK-cell lymphoma/leukemia as shown by spectral karyotyping. Hum Pathol. 2000;31:771–774
  9. Siu LL, Wong KF, Chan JK, Kwong YL. Comparative genomic hybridization analysis of NK cell lymphoma/leukemia. Recognition of consistent patterns of genetic alterations. Am J Pathol. 1999;155:1419–1425
  10. Zhang Y, Wong KF, Siebert R, Matthiesen P, Harder S, Eimermacher H, et al. Chromosome aberrations are restricted to the CD56+, CD3-tumour cell population in NK cell lymphomas: a combined immunophenotyping and FISH study. Br J Haematol. 1999;105:737–742
  11. Drexler HG. The Leukemia/Lymphoma Cell Line FactsBook. San Diego: Academic Press, 2001.
  12. Drexler HG, Matsuo Y. Malignant hematopoietic cell lines: in vitro models for the study of NK cell leukemia/lymphoma. Leukemia. 2000;14:777–782
  13. Korbelik M, Sun J. Cancer treatment by photodynamic therapy combined with adoptive immunotherapy using genetically altered NK cell line. Int J Cancer. 2001;93:269–274
  14. Maki G. Ex vivo purging of stem cell autografts using cytotoxic cells. J Hematother Stem Cell Res. 2001;10:545–551
  15. Tonn T, Becker S, Esser R, Schwabe D, Seifried E. Cellular immunotherapy of malignancies using the clonal NK cell line NK-92. J Hematother Stem Cell Res. 2001;10:535–544
  16. MacLeod RA, Dirks WG, Matsuo Y, Kaufmann M, Milch H, Drexler HG. Widespread intraspecies cross-contamination of human tumor cell lines arising at source. Int J Cancer. 1999;83:555–563
  17. Gong JH, Maki G, Klingemann HG. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated NK cells. Leukemia. 1994;8:652–658
  18. Maki G, Klingemann HG, Martinson JA, Tam YK. Factors regulating the cytotoxic activity of the human NK cell line, NK-92. J Hematother Stem Cell Res. 2001;10:369–383
  19. Drexler HG, Dirks W, MacLeod RAF, Steube KG, Uphoff CC. Catalogue of Human and Animal Cell Lines. 8th ed. DSMZ: Braunschweig, 2001.
  20. MacLeod RA, Spitzer D, Bar-Am I, Sylvester JE, Kaufmann M, Wernich A, et al. Karyotypic dissection of Hodgkin’s disease cell lines reveals ectopic subtelomeres and ribosomal DNA at sites of multiple jumping translocations and genomic amplification. Leukemia. 2000;14:1803–1814
  21. Sunwoo JB, Sun PC, Gupta VK, Schmidt AP, El-Mofty S, Scholnick SB. Localization of a putative tumor-suppressor gene in the sub-telomeric region of chromosome 8p. Oncogene. 1999;18:2651–2655
  22. Ishii H, Vecchione A, Murakumo Y, Baldassarre G, Numata S, Trapasso F, et al. FEZ1/LZTS1 gene at 8p22 suppresses cancer cell growth andregulates mitosis. Proc Natl Acad Sci U.S.A. 2001;98:10374–10379
  23. Heim S Mitelman F. Cancer Cytogenetics. 2nd ed. New York: Wiley, 1995.
  24. Baldassarre G, Fedele M, Battista S, Vecchione A, Klein-Szanto AJ, Santoro M, et al. Onset of NK cell lymphomas in transgenic mice carrying a truncated HMGI-C gene by the chronic stimulation of the IL-2 and IL-15 pathway. Proc Natl Acad Sci U.S.A. 2001;98:7970–7975
  25. Sakajiri S, Kawamata N, Egashira M, Mori K, Oshimi K. Molecular analysis of tumor-suppressor genes, Rb, p53, p16INK4A, p15INK4B and p14ARF in NK cell neoplasms. Jpn J Cancer Res. 2001;92:1048–1056
  26. Yagita M, Huang CL, Umehara H, Matsuo Y, Tabata R, Miyake M, et al. A novel NK cell line (KHYG-1) from a patient with aggressive NK cell leukemia carrying a p53 point mutation. Leukemia. 2000;14:922–930
  27. Robertson MJ, Cochran KJ, Cameron C, Le JM, Tantravahi R, Ritz J. Characterization of a cell line, NKL, derived from an aggressive human NK cell leukemia. Exp. Hematol. 1996;24:406–415
  28. Tsuchiyama J, Yoshino T, Mori M, Kondoh E, Oka T, Akagi T, et al. Characterization of a novel human natural killer-cell line (NK-YS) established from NK cell lymphoma/leukemia associated with EBV infection. Blood. 1998;92:1374–1383
  29. Yodoi J, Teshigawara K, Nikaido T, Fukui K, Noma T, Honjo T, et al. TCGF (IL-2)-receptor inducing factor(s). I. Regulation of IL-2 receptor on a NK-like cell line (YT cells). J Immunol. 1985;134:1623–1630

PII: S0145-2126(02)00055-3

Leukemia Research
Volume 26, Issue 11 , Pages 1027-1033 , November 2002

Article Tools

* Image Usage & Resolution